<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02842268</url>
  </required_header>
  <id_info>
    <org_study_id>18818</org_study_id>
    <nct_id>NCT02842268</nct_id>
  </id_info>
  <brief_title>Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating</brief_title>
  <official_title>Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after
      exercise compared to the full coverage observed prior to exercise.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 17, 2016</start_date>
  <completion_date type="Actual">June 22, 2016</completion_date>
  <primary_completion_date type="Actual">June 22, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of face coverage post exercise compared to the full coverage observed prior to exercise (in percent).</measure>
    <time_frame>At baseline and post exercise (30 minutes)</time_frame>
    <description>Done with a Skin Scanner( before and after each exercise session) using the 11-point scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eye Stinging on grading scale</measure>
    <time_frame>Up to 30 mins</time_frame>
    <description>On scale:0 = None,1 = Slight,2 = Mild,3 = Moderate, 4 = Severe</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>Sunscreening Agent</condition>
  <arm_group>
    <arm_group_label>BAY987517</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will self-apply the test sunscreen formula to his/her face with the goal of applying 0.65 to 0.85 grams.Subject should sweat profusely.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BAY987517</intervention_name>
    <description>Test product dried for at least 15 minutes.Subjects to ride for 30 minutes on a stationary bicycle.(Formulation Number :Y73-161)</description>
    <arm_group_label>BAY987517</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects may be male or female, of an age of 18-55 years inclusive.

          -  Subjects must be capable of understanding and providing written informed consent.

          -  Subjects must sign a written confidentiality agreement including a photography release
             form.

          -  Subjects must be in good general health as judged by a specified licensed physician,
             who will indicate their suitability to participate in this study.

          -  Female subjects must be willing to take a rapid screen pregnancy test prior to each
             exercise session.

          -  Subjects must be willing to follow study instructions as set forth in the protocol.

          -  Subjects must not have facial piercing(s).

          -  Subjects must be Fitzpatrick Skin Type I, II, or III.

        Exclusion Criteria:

          -  Subjects must not have received or used an Investigational New Drug within the last 30
             days.

          -  Subjects must not have been active participants in another clinical or subjective TP
             performance study within the last 30 days unless authorized by this Sponsor.

          -  Subjects must not have a known physical or medical condition that would preclude
             vigorous exercise

          -  Subjects must not have a five-minute resting pulse rate greater than 80 bpm.

          -  Subjects must not take any chronic medication other than vitamins, hormone replacement
             therapy, low-dose aspirin, or oral contraceptives.

          -  Subjects must not have applied prescription or over-the-counter medicines to their
             face at least 96 hours prior to exercise session

          -  Subjects must not have a known allergy or sensitivity to sunscreen products or
             Cetaphil cleanser.

          -  Female subjects must not be pregnant (self-reported) or test positive using an on-site
             pregnancy test.

          -  Female subjects must not be nursing a child.

          -  Subjects must not have smoked cigarettes, pipes, or cigars in the last 60 days.

          -  Subjects who in the judgment of the Investigator have any condition that would make
             study participation inappropriate.

          -  Subjects must not be a member or relative of the clinical trial staff or the Sponsor
             directly involved in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Saint Petersburg</city>
        <state>Florida</state>
        <zip>33714</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <link>
    <url>http://pharma.bayer.com/en/innovation-partnering/clinical-trials/trial-finder/</url>
    <description>Click here to find results for studies related to Bayer products.</description>
  </link>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>July 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2016</study_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sunscreening Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

